Two reviewers independently screened the titles, abstracts, and full texts of selected articles. Eligible studies included in this meta-analysis were complied with the following criteria: related to the diagnostic value of miRNAs for CRC; gold standard for CRC detection was specified; offered sufficient data to calculate estimates of true positives/false positives and false/true negatives that were used to evaluate the sensitivity, specificity, and sample size. Exclusion criteria were set as follows: publications that were unrelated to the diagnostic value of miRNAs for CRC; studies with duplicated or incomplete data; letters, editorials, commentaries, reviews, or case reports; studies that were not conducted on humans.
Two independent reviewers extracted the following data from eligible studies: the first author, publication year, country, ethnicity, sample size of the case/control group, tumor stages, miRNA profiling, specimen sources, and relevant data for meta-analysis (sensitivity and specificity).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.